How does the increased GFR during pregnancy influence pharmacokinetics of renally excreted medications?

How does the increased GFR during pregnancy influence pharmacokinetics of renally excreted medications?

• A. May shorten the half-life of renally excreted medications
• B. Prolongs the half-life of renally excreted medications
• C. Has no effect on drug half-life
• D. Requires less frequent dosing due to increased clearance

Answer: (A)

During pregnancy, renal blood flow and glomerular filtration rate rise, so the kidneys clear renally excreted drugs more quickly. Because half-life is determined by how fast a drug is cleared (t1/2 ≈ 0.693 × Vd / CL), increased clearance shortens the half-life of these medications. This can lead to lower and shorter-lived drug levels, sometimes necessitating higher or more frequent dosing to maintain efficacy. The other statements don’t fit: faster clearance does not prolong half-life, it does not leave half-life unchanged, and it typically requires at least as frequent dosing rather than less frequent dosing.

During pregnancy, renal blood flow and glomerular filtration rate rise, so the kidneys clear renally excreted drugs more quickly. Because half-life is determined by how fast a drug is cleared (t1/2 ≈ 0.693 × Vd / CL), increased clearance shortens the half-life of these medications. This can lead to lower and shorter-lived drug levels, sometimes necessitating higher or more frequent dosing to maintain efficacy. The other statements don’t fit: faster clearance does not prolong half-life, it does not leave half-life unchanged, and it typically requires at least as frequent dosing rather than less frequent dosing.